Pharma Deals Review, Vol 2008, No 96 (2008)

Font Size:  Small  Medium  Large

Ranbaxy and Merck & Co. Team Up To Develop Novel Anti-Infectives

Helen Scrutton

Abstract


Merck & Co entered into an agreement with Ranbaxy Laboratories to develop clinically validated anti-bacterial and anti-fungal drug candidates.

Full Text: pdf html

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.